Pathology Laboratories, Inc.

pathlabs.org

Established in Toledo, Ohio in 1946, Pathology Laboratories, Inc. (PathLabs) fostered a reputation among the area’s private medical practitioners as a provider of prompt, reliable and convenient laboratory testing services. Its status as a key partner in the delivery of quality medical care to the community was advanced in 1970 when PathLabs became the first independent medical laboratory in Ohio to seek and attain accreditation by the College of American Pathologists - the preeminent laboratory certifying body in the nation. Over the ensuing decades, PathLabs continued its tradition of uncompromising quality, personal service and overall excellence to become the dominant full-service independent medical laboratory in northwest Ohio and southeast Michigan. Since 2004, we have rapidly expanded our operations to other areas of Ohio including Cleveland, Columbus and Lima and their surrounding communities.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Business Insights

LIGAND AND GSK EXPAND GLOBAL COLLABORATION AND LICENSE AGREEMENT

Ligand Pharmaceuticals | December 22, 2021

news image

Ligand Pharmaceuticals Incorporated announced today the expansion of an existing collaboration and license agreement between its subsidiary, Icagen, and GlaxoSmithKline. The expansion will leverage Icagen’s ion-channel-based discovery technology and unique expertise in small molecule therapeutics targeting transmembrane proteins. This new agreement builds upon the initial December 2020 agreement to identify and develop inhibitors of a specific genetically-validated molecular target relevan...

Read More

Business Insights

SINORDA BIOMEDICINE AND PORTON ADVANCED TO FAST-TRACK THE DEVELOPMENT OF CELL THERAPIES FOR SOLID TUMORS

Porton Advanced | April 25, 2022

news image

Suzhou Porton Advanced Solutions Ltd. and Guizhou Sinorda Biomedicine Co. Ltd. announced a long-term strategic relationship in cell and gene therapy research and development and platform development. Porton Advanced provides plasmids, cell therapy, gene therapy, oncolytic virus, mRNA treatment, and bacterial therapy as part of an end-to-end gene and cell therapy CDMO service platform. Sinorda Biomedicine focuses on the R&D of revolutionary drugs for digestive tract disorders, ...

Read More

Business Insights

BASETWO LAUNCHES NO-CODE ARTIFICIAL INTELLIGENCE PLATFORM FOR PHARMACEUTICAL MANUFACTURING, RAISES $3.8 MILLION

Basetwo | May 27, 2022

news image

Basetwo, a SaaS AI platform for manufacturers, announced it secured a $3.8M seed round led by Glasswing Ventures and Argon Ventures with additional funding from Caffeinated Capital, Graphite Ventures, MaRs IAF, Pareto Holdings, Plug and Play, and Quiet Capital. The funding supports the launch of the category-making Basetwo AI platform, a first-of-its-kind solution that enables process engineers to rapidly build digital twins of their manufacturing plants leveraging a familiar no-c...

Read More

Pharmacy Market

MEDNOW ANNOUNCES PHARMACY PARTNERSHIP AGREEMENT WITH SERVICEPLUS, A NATIONAL TOTAL REWARDS PLATFORM OPERATED BY PIPSC

Businesswire | June 20, 2023

news image

Mednow Inc. Canada’s on-demand virtual pharmacy, is pleased to announce that the Company has executed a Preferred Pharmacy Agreement with ServicePlus, a leading provider of Member Benefit and rewards services. The agreement allows ServicePlus members to leverage enhanced services and preferred pricing from Mednow digital pharmacy and healthcare platform to its clients and plan members. "Mednow is thrilled to partner with ServicePlus to expand access to virtual pharmac...

Read More
news image

Business Insights

LIGAND AND GSK EXPAND GLOBAL COLLABORATION AND LICENSE AGREEMENT

Ligand Pharmaceuticals | December 22, 2021

Ligand Pharmaceuticals Incorporated announced today the expansion of an existing collaboration and license agreement between its subsidiary, Icagen, and GlaxoSmithKline. The expansion will leverage Icagen’s ion-channel-based discovery technology and unique expertise in small molecule therapeutics targeting transmembrane proteins. This new agreement builds upon the initial December 2020 agreement to identify and develop inhibitors of a specific genetically-validated molecular target relevan...

Read More
news image

Business Insights

SINORDA BIOMEDICINE AND PORTON ADVANCED TO FAST-TRACK THE DEVELOPMENT OF CELL THERAPIES FOR SOLID TUMORS

Porton Advanced | April 25, 2022

Suzhou Porton Advanced Solutions Ltd. and Guizhou Sinorda Biomedicine Co. Ltd. announced a long-term strategic relationship in cell and gene therapy research and development and platform development. Porton Advanced provides plasmids, cell therapy, gene therapy, oncolytic virus, mRNA treatment, and bacterial therapy as part of an end-to-end gene and cell therapy CDMO service platform. Sinorda Biomedicine focuses on the R&D of revolutionary drugs for digestive tract disorders, ...

Read More
news image

Business Insights

BASETWO LAUNCHES NO-CODE ARTIFICIAL INTELLIGENCE PLATFORM FOR PHARMACEUTICAL MANUFACTURING, RAISES $3.8 MILLION

Basetwo | May 27, 2022

Basetwo, a SaaS AI platform for manufacturers, announced it secured a $3.8M seed round led by Glasswing Ventures and Argon Ventures with additional funding from Caffeinated Capital, Graphite Ventures, MaRs IAF, Pareto Holdings, Plug and Play, and Quiet Capital. The funding supports the launch of the category-making Basetwo AI platform, a first-of-its-kind solution that enables process engineers to rapidly build digital twins of their manufacturing plants leveraging a familiar no-c...

Read More
news image

Pharmacy Market

MEDNOW ANNOUNCES PHARMACY PARTNERSHIP AGREEMENT WITH SERVICEPLUS, A NATIONAL TOTAL REWARDS PLATFORM OPERATED BY PIPSC

Businesswire | June 20, 2023

Mednow Inc. Canada’s on-demand virtual pharmacy, is pleased to announce that the Company has executed a Preferred Pharmacy Agreement with ServicePlus, a leading provider of Member Benefit and rewards services. The agreement allows ServicePlus members to leverage enhanced services and preferred pricing from Mednow digital pharmacy and healthcare platform to its clients and plan members. "Mednow is thrilled to partner with ServicePlus to expand access to virtual pharmac...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us